Serum chloride and the response to acetazolamide in patients with acute heart failure and volume overload: a post-hoc analysis from the ADVOR trial

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Acute, advanced and worsening heart failure: prognostic aspects Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by